Journal of Nuclear Medicine: 53 (9)

September 1, 2012; Volume 53,Issue 9

Cover image

This image shows the lymphatics and the main nodal stations in a mouse after injection of ¹⁸F-FDG intracutaneously into the tail in a 3-dimensional PET/CT reconstruction.
See page 1438.

In this issue

Issue highlights

¹⁸F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology
Positron Lymphography: Multimodal, High-Resolution, Dynamic Mapping and Resection of Lymph Nodes After Intradermal Injection of ¹⁸F-FDG

Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Head-to-Head Comparison of ⁶⁸Ga-PSMA-11 with ¹⁸F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to